Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial Hypertension

Clinical trial NCT00423592 · COMPLETED

Trial details

NCT number: NCT00423592
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Hypertension

Start date: 2005-05-01
Primary completion: 2006-01-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.